Wednesday brings a landmark for cannabis capital markets, with Trulieve set to become the first US plant-touching operator to open trading on the New York Stock Exchange and Verano preparing its own exchange push via a reverse stock split. In Virginia, Governor Spanberger’s negotiations with legislators over adult-use sales are converging on a 1 July budget deadline. The EU Drugs Agency’s 2026 annual report, released in Brussels on Tuesday, places 25 million adults in the cannabis-using population across Europe and warns of a decade-long potency surge.

Trulieve Set to Become First US Cannabis Stock to Trade on the NYSE

Trulieve Cannabis Corp’s subordinate voting shares are due to begin trading on the New York Stock Exchange today under the ticker TRLV, making the Florida-based multistate operator the first plant-touching US company to list on a major American exchange. The milestone follows Acting Attorney General Todd Blanche’s April 2026 reclassification of state-licensed medical cannabis to Schedule III, which cleared the path for exchange eligibility. Shanken News Daily reports the company posted $287 million in first-quarter revenue across 206 dispensaries, having previously traded on the Canadian Securities Exchange and OTCQX. Investors following the broader equities picture can track developments at the Cannabis Stocks Tracker.

Verano Sets 1-for-5 Reverse Stock Split Ahead of Major Exchange Push

Verano Holdings Corp. is pursuing its own route to a major US exchange listing, with a 1-for-5 reverse stock split expected to take effect on or around 11 June. The restructuring will reduce the Illinois-based operator’s outstanding shares from roughly 364 million to approximately 73 million, delivering a share-price increase Verano says meets standard exchange eligibility thresholds. As Shanken News Daily reports, the company’s Q1 2026 revenue reached $208 million, with adjusted EBITDA of $49 million across 162 dispensaries. Chief executive George Archos described the split as part of “a series of strategic initiatives” positioning Verano ahead of domestic capital market opportunities following federal rescheduling.

Virginia Governor Calls Legalisation Talks “Incredible” as July Budget Deadline Nears

Virginia Governor Abigail Spanberger described ongoing negotiations with state legislators over adult-use cannabis sales as “incredible and productive” in a Monday statement, raising the prospect of a deal clearing before the 1 July budget deadline. Marijuana Moment reports that Spanberger is working with Del. Paul Krizek and Sen. Lashrecse Aird, who sponsored the bill she vetoed in May over concerns about timeline, tax rates and dispensary density. Both sides report substantial progress, with a budget vehicle under discussion that would allow the reforms to advance without a standalone bill. Virginia currently permits personal possession but has no licensed retail market.

Multiple Legal States Raise Cannabis Possession Limits in 2026

A pattern of upward revisions to personal cannabis possession allowances is taking shape across US legal states, with Illinois, Vermont and Massachusetts all passing or advancing legislation this year. Illinois doubled its carry limit to 60 grams of flower under a sweeping omnibus bill heading to Governor Pritzker’s desk. Vermont increased its threshold to two ounces, and Massachusetts raised its own from one ounce to two. As Marijuana Moment reports, the Marijuana Policy Project argues the trend reflects recognition that low limits “unnecessarily ensnare residents in the criminal justice system” while preventing consumers from buying practical quantities at a single licensed dispensary visit.

EU Drugs Agency Flags Potency Surge and North American Contamination Risk in Annual Report

The European Union Drugs Agency published the European Drug Report 2026 at a Brussels launch event on Tuesday, presenting data that will inform the regulatory debate across member states. The report estimates 25 million European adults — 8.7 per cent of the 15–64 age group — used cannabis in the past year, with the rate rising to 18 per cent among those aged 15 to 24. THC content in seized cannabis resin averaged 24.6 per cent in 2024, double the level found in herbal cannabis and 66 per cent higher than a decade ago. The agency identified the spread of potent, pesticide-contaminated North American supply as an emerging public health concern. Full regulatory context is available at the EU Cannabis Regulation hub.

Watch this weekend for developments in Virginia’s budget negotiations, which must clear both chambers before 1 July. The DEA’s expedited rescheduling hearing opens 29 June as legal challenges from state attorneys general and industry participation filings accumulate.